story of the week
Perioperative Durvalumab for Resectable NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
N. Engl. J. Med 2023 Nov 02;389(18)1672-1684, JV Heymach, D Harpole, T Mitsudomi, JM Taube, G Galffy, M Hochmair, T Winder, R Zukov, G Garbaos, S Gao, H Kuroda, G Ostoros, TV Tran, J You, KY Lee, L Antonuzzo, Z Papai-Szekely, H Akamatsu, B Biswas, A Spira, J Crawford, HT Le, M Aperghis, GJ Doherty, H Mann, TM Fouad, M ReckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.